Biotech Values

[DewDiligence]

So PPHM has facilities to manufacture biopharmaceuticals—how is that enough to make them a serious player in FoB’s?

I think the answer is that PPHM is defining an FoB as almost any biopharmaceutical—whether or not the development program is based on characterizing and reverse-engineering another company’s product. By this definition, PPHM’s claims with respect to FoB’s are essentially meaningless, IMO.